Aug
22

What’s going to drive real change in workers’ comp

It’s not regulators, employers, providers, or insurers.

It’s not judges, advocacy groups, or bloggers. Not employment changes, on-shoring, infrastructure investment or Obamacare.

It’s private equity.

There are dozens of PE firms looking hard at this business, with many heavily involved in bidding on past and present opportunities.  There are several reasons for this interest;

  • other PE firms are interested, and there’s a bit of herd mentality at play here
  • investors are increasingly leery of health care/insurance sector plays focused on care regulated by PPACA; some functionary at CMS could blow up an entire business model by changing a few words in a few regulations, and that’s just too risky.
  • the deals are getting bigger – much bigger.  Some PE firms don’t play in the hundred million to a few hundred million dollar range; as the deal size grows the mix of firms involved does too.
  • work comp is STILL seen as an aging, creaky dysfunctional industry ripe for process improvement and increased efficiency.

This last bullet is to the point.  The more that these PE firms are involved, the more they will seek to modernize the industry.  While the founders, and initial investors in work comp firms made their millions navigating thru the mess, and in many cases taking advantage of the very dysfunction that defines workers comp, the new owners have little patience for this, and a wealth of experience squeezing inefficiencies out of systems.

They will engage lobbyists and hire ex-regulators, invest in technology, build strong co-operative relationships, relentlessly reduce cost, and listen very, very hard. And when they act it will be decisive.

Of course it’s going to be difficult and time-consuming and frustrating, but these folks have done this before, and they’re about to do it again.

What does this mean for you?

Things will get faster smarter and more efficient, to the benefit of many and the detriment of some.

 


Aug
20

Immigrants in the workforce – and implications thereof

One of every seven workers in the US is foreign-born.

About half are Hispanic and a quarter Asian.  About a third of the foreign born workers are undocumented.

We’ll leave aside the problems with immigration regulation, drivers thereof, lazy Americans, and all the rest of the and focus on the impact of these foreign-born folks on workers’ comp.

Today’s WorkCompWire features a piece by friend and colleague Peter Rousmaniere on the subject; Peter’s been tracking this very closely for years, and is the most knowledgeable person I know on the subject.  Here’s a key passage:

When you estimate the number of future work injuries, taking into account the injury rates of the individual jobs and their expected growth of openings, you find that immigrant workers will likely sustain 20% — one of every five – of work injuries. (emphasis added)

Here are just a few of the implications I see; as the acknowledged expert Peter’s got a much deeper and broader perspective.

  • Most of these workers likely won’t know much about the US health care system or workers’ comp, and will get that information from people they know and trust – their fellow countrymen.
  • Many may not have primary care physicians, so will seek care at the most convenient/nearest location.
  • The language issues are both obvious and subtle; even those with passable English skills may not fully grasp what they’re hearing and reading, leading to mis-interpretations and misunderstanding.

With the share of jobs held by first-generation immigrants going to increase steadily for the foreseeable future, payers and service companies alike are going to have to alter their practices to accommodate an evolving workforce.

What does this mean for you?

Recognizing the reality will be much more productive than ranting about it.


Aug
19

It’s been a busy summer in the work comp sales world

The days of summer  – and particularly August – being slow for the work comp services business are over – at least for this year.

Word is the North Dakota state fund aka WSI, has chosen PBM PMSI to handle their work comp pharmacy requirements.  The Tampa-based PBM took the business from US Script; with the extractive industries’ employment zooming – and likely claims severity and frequency as well – this should be a nice addition to the portfolio.

CompSource OK – another state fund – is moving/has moved their bill review business to Medata. No official announcement here, and no other vendor lost the business as the inplace technology was a home-grown system.

Given the expected appearance of a “for sale” sign on Mitchell, there’s going to be a lot more action in the bill review market.  No word on Aetna’s plans for Coventry’s BR 4.0 platform, but there’s no doubt the increasingly creaky infrastructure will require some major investment, a complete re-write, or perhaps they’ll just blow it up and move to a current rival platform.

TPA QBE will be utilizing Sedgwick’s for claims adjudication – the TPA will be outsourcing some/a chunk of/most of that work to Sedgwick.  

I’m not in Orlando at the WCI Conference, so no reports from the Sunshine State, at least nothing first-hand.

Enjoy the week.

 


Aug
15

Highlights of the Survey of Drug Management in Work Comp – 2013 edition

Payers’ views of drug management in workers’ comp have evolved dramatically over the last decade; here are a few initial takeaways from the 10th Annual Survey of Prescription Drug Management in Worker’s Compensation.

  • For the third consecutive year, respondents’ drug costs declined in real terms, both for the average across all respondents (-3.9%) and the average of each respondent (-3.7%).
  • On a scale of 1 through 5 with 3 being “drug costs are equally as important as other medical cost issues,” drug costs were rated a 3.9, or “more important than other medical cost issues.”

  • Respondents are concerned (4.0) that drug costs will be more of a problem in the next 12-24 months than they are today.

  • Respondents deemed opioid prescribing, dispensing, monitoring, and management as the most important way to control workers’ compensation pharmacy costs. Respondents judged opioids to be an extremely significant problem, giving it an average of 4.8. This remains the highest score for any survey question in the history of the survey
  • All but one respondents had made significant upgrades and improvements to their clinical programs in 2012 

We’ve been surveying workers’ comp payers about their views on prescription drug management for ten years now, and the results from this year’s Survey show a remarkable increase in respondents’ expertise, depth of knowledge, and level of sophistication.  The responses to qualitative questions revealed most respondents are far more familiar with all aspects of the drug issue than they were a decade ago.

It is no surprise, then, that costs have declined over the last few years.  While there have undoubtedly been external factors that have contributed to that happy event, there’s also no question that the payers’ focus on this issue is paying off – in lower costs, better care, and reduced premiums.

That said, the looming opioid crisis will require a redoubling of that focus if payers are going to avoid the potentially devastating long-term financial consequences of opioid usage.

Past surveys are available here; a public version of the 2013 Survey will be available next week; I’ll let you know when it is.


Aug
14

Survey – Opioids and Workers’ Compensation

It is NO secret that opioids are an issue for the workers’ compensation industry – the cost of the average lost-time claim with long acting opioids 900% higher than those without.

What is a secret is why there’s a picture of an iPad Mini here (see last paragraph for details)…

iPad_mini_MQ

We do know (thanks to a story published in The New York Times’ June 22, 2013 entitled “The Soaring Cost Of the Opioid Economy,”) the stronger the opioid, the higher the expense of the claim as:

  • the average cost of claims without opioids is $13,000;
  • the average cost with a short-acting opioid e.g. Percocet is $39,000 (300% of avg.);
  • the average cost with a long-acting opioid e.g. OxyContin is $117,000 (900% of avg.); and,
  • between 2001 and 2008, narcotics prescriptions as a share of all drugs used to treat workplace injuries jumped 63 percent, according to insurance industry data.

The claims cost while enormous seems small in comparison to the human toll that opioids are taking on families and friends. Opioids are highly addictive and are robbing users of their lives as they knew them and by taking them:

·      U.S. EMERGENCY ROOM COSTS Cases in which an opioid other than heroin was cited as a reason for an emergency-room treatment in 2004 – 299,498 and in 2011 – 885,348 (almost a 300% increase).

·      OVERDOSE DEATHS Where prescription opioids were involved in 1999 – 4,030 and in 2010 – 16,651 (over a 400% increase).

·      DRUGS FOR OPIOID ADDICTION The number of prescriptions dispensed for two drugs increasingly given to treat opioid addiction — buprenorphine and naltrexone — has soared along with opioid use from almost zero in 2002 to 8 million prescriptions in 2012.

·      PATIENTS IN ADDICTION TREATMENT Number of patients in a one-day survey at facilities that use methadone or buprenorphine to treat addiction to pain pills or heroin has risen from 228,140 in 2002 to 313,460 in 2011. (Does not include all patients treated at doctors’ offices.)

What we don’t know is payers’ perceptions, programs, and results.  To that end, we are conducting an online Survey of Opioids and Workers’ Compensation; seeking information about what payers think and are doing about opioids; how opioids are affecting loss costs, claims handling, and claim closure; what management programs are working and what aren’t; the role of the adjuster and PBM; what role opioids should play in worker’s comp; and what the future holds.

Click here to complete the Survey

Couple details –

  • all survey respondents get a detailed copy of the Survey Report
  • one respondent will get a16Gb iPad Mini in the color of her/his choice
  • all responses are confidential

Aug
12

Quick catch-up on the events of the week

Hard as it is to believe, the world kept turning while MCM was on vacation, with nary a wobble to mark our hiatus.

Here’s a quick summary of things that happened while we were away…

Medicare physician reimbursement

Congress may – at long last – kill the oft-derided and pretty-much-useless Medicare physician payment update methodology knows as the Sustainable Growth Rate.  Useless because Congress overrides it on an annual basis, as SGR requires cuts in reimbursement to keep Medicare’s doc costs under control.  A bill advancing in the GOP-controlled House of Representatives seeks to replace SGR with an annual increase of 0.5%, ending in 2018 with a to-be-developed methodology based on quality and performance.

In the work comp world, almost all provider fee schedules are based – to one degree or another – on Medicare’s RBRVS. This change will directly impact reimbursement in a few states, and indirectly in all as the unforeseen consequences of price management become apparent. (An excellent source for information on state fee schedules is available from WCRI.)

The latest edition of Health Affairs has a great piece about CalPERS’ use of reference pricing to influence their members’ choice of hospitals…

in response to a fivefold variation in prices it paid on behalf of members who underwent knee and hip replacement surgery. Under this benefit design, an insurer places limits on the amount it will pay for a procedure, with employees paying the difference if they select a higher-price hospital. Based on first-year results from forty-one hospitals identified as value-based purchas- ing design facilities, surgical volumes for CalPERS members increased by 21.2 percent at low-price facilities and decreased by 34.3 percent at high-price hospitals. [emphasis added]

Gotta love the effective use of the power of information.

There is more information coming out – seemingly every day – on rates filed for the health insurance Exchanges.  Another piece in Health Affairs explores why there’s wide variation in rates in some states – and very little variation in others.  One clue – “In contrast to the 34 states where the federal government is operating the exchange as a clearinghouse that will accept all insurers who meet minimum standards, Covered California negotiated rates with each insurer with the implicit threat that the Exchange would exclude any insurer who did not come up with an acceptable rate. ” California’s rates showed the least amount of variation…

Obesity has been classified as a disease by the AMA, a change that may well impact work comp claims, claims management, costs, and therefore system costs. CWCI research found:

“average benefit payments on indemnity claims with the obesity co-morbidity were $116,437, or 81.4 percent more than those without; and that these claims averaged nearly 35 weeks of lost time, or 80% more than the average of 19 weeks for claims without the obesity co-morbidity.”

There’s a lot more brewing out there with deals-aplenty, but I’ve got to catch up on emails and calls and stuff that didn’t get done last week, so they’ll have to wait till tomorrow.


Aug
5

MCM’s on holiday

This week I’m on vacation in New York’s Finger Lakes – as my lovely bride has a strict “no work on vacation” policy, and I really like being married, there will be no posts on MCM this week.

Hope yours is excellent.


Aug
2

Brighter days ahead for work comp

If your definition of “brighter days” is based on higher total premiums, things are looking decidedly sunny.

Factory orders are up significantly, which should lead to higher manufacturing employment.  As these jobs are typically higher risk than average, premiums will be proportionally higher as well.

Other positive indicators include a reduction in initial jobless claims and a healthy increase in private sector employment fueled by construction and trade/transportation/utilities.

If the knuckleheads on Capitol Hill could get their act together and end this stupider-than-stupid sequester, we’d see another 0.5% or more in GDP growth.  Alas, it does not look like sanity will arrive any time soon.

With rates up, employment up, and wages slightly higher, comp’s top line – revenues – will be steadily improving.  

The real issue is claims cost, and more specifically medical expense.  Anecdotal information from discussions with claims execs at several very large payers suggests growing unease about medical trend. Some may chalk that up to comp folks’ inability to ever be completely happy; I’d say they are realistic.

What does this mean for you?

With higher premiums come more dollars to invest in medical management. After hollowing out departments, cutting staff, avoiding IT investment, and counting managed care service fees as “revenue”, payers had best get back to real medical management.  


Aug
1

Lousy back pain care – it’s not just work comp

What’s changed in treating back pain over the last decade?

More narcotics and fewer NSAIDs.  More referrals to specialists, less treatment by primary care docs.  More MRIs and CTs.  

A really illuminating article just published in JAMA provided those insights and more, concluding “Despite numerous published clinical guidelines, management of back pain has relied increasingly on guideline discordant care.”

Like 29% of patients prescribed narcotics.

In other words, more care, delivered by more expensive providers, with higher risks, despite no evidence it improves results.

Not only do we have a looooong way to go, it’s getting longer every day…